fda bpc-157 immunogenicity concerns Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157: The Real Reason Why
Description
Much of what circulates online is speculation
[DOI] [PubMed] [Google Scholar] 203.Lozic M., Stambolija V., Krezic I., Dugandzic A., Zivanovic-Posilovic G., Gojkovic S., Kovacevic J., Vrdoljak L., Mirkovic I., Kokot A., et al
Dec 1996;271(6 Pt 2):F1114-1122
It is the first clue that this compound interacts with biological systems in ways that standard peptide pharmacology does not predict
